<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37704548</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-4981</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Trends in immunology</Title><ISOAbbreviation>Trends Immunol</ISOAbbreviation></Journal><ArticleTitle>Over but not gone: lingering epigenetic effects of COVID-19.</ArticleTitle><Pagination><StartPage>751</StartPage><EndPage>753</EndPage><MedlinePgn>751-753</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.it.2023.08.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1471-4906(23)00180-1</ELocationID><Abstract><AbstractText>'Long COVID' affects nearly one in five adults who have had coronavirus disease 2019 (COVID-19), yet the mechanisms underlying this disorder remain poorly understood. In a new study, Cheong et al. show that the epigenetic and transcriptional state of myeloid immune cells and their progenitors are durably altered in patients following severe COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Brandon T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Program in Cancer and Cell Biology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Ruoqiong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Program in Immunology and Microbiology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Katherine Y</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Program in Cancer and Cell Biology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, USA; Program in Immunology and Microbiology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, USA; Department of Pediatrics, Division of Infectious Disease, Baylor College of Medicine, Houston, TX, USA. Electronic address: Kyk@bcm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI141716</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL155672</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL092332</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 CA265748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 HL164287</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Immunol</MedlineTA><NlmUniqueID>100966032</NlmUniqueID><ISSNLinking>1471-4906</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>21</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37704548</ArticleId><ArticleId IdType="mid">NIHMS1928888</ArticleId><ArticleId IdType="pmc">PMC10543559</ArticleId><ArticleId IdType="doi">10.1016/j.it.2023.08.012</ArticleId><ArticleId IdType="pii">S1471-4906(23)00180-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A et al. (2021) Post-acute COVID-19 syndrome. Nat Med 27 (4), 601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JM (2022) Multisystem Inflammatory Syndrome in Children (MIS-C). Curr Allergy Asthma Rep 22 (5), 53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938222</ArticleId><ArticleId IdType="pubmed">35314921</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong J et al. (2023) Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell. S0092-8674(23)00796-1. doi: 10.1016/j.cell.2023.07.019. Online ahead of print</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.07.019</ArticleId><ArticleId IdType="pmc">PMC10638861</ArticleId><ArticleId IdType="pubmed">37597510</ArticleId></ArticleIdList></Reference><Reference><Citation>de Laval B et al. (2020) C/EBPbeta-Dependent Epigenetic Memory Induces Trained Immunity in Hematopoietic Stem Cells. Cell Stem Cell 26 (5), 793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32386557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain BN et al. (2023) Hematopoietic stem and progenitors cells confer cross-protective trained immunity in mouse models. iScience 26 (9), 107596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10470378</ArticleId><ArticleId IdType="pubmed">37664586</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen SB et al. (2021) Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 28 (10), 1758&#x2013;1774 e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500942</ArticleId><ArticleId IdType="pubmed">34320411</ArticleId></ArticleIdList></Reference><Reference><Citation>Le DT et al. (2023) BATF2 promotes HSC myeloid differentiation by amplifying IFN response mediators during chronic infection. iScience 26 (2), 106059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9942003</ArticleId><ArticleId IdType="pubmed">36824275</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerosa RC et al. (2021) CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis. Blood Adv 5 (23), 5002&#x2013;5015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9153025</ArticleId><ArticleId IdType="pubmed">34581809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann E et al. (2018) BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell 172 (1-2), 176&#x2013;190 e19.</Citation><ArticleIdList><ArticleId IdType="pubmed">29328912</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutgers A et al. (2022) Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients. PLoS One 17 (8), e0271807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9374226</ArticleId><ArticleId IdType="pubmed">35960720</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>